Published in Diabetes Obes Metab on January 25, 2013
Granulomatous infectious diseases associated with tumor necrosis factor antagonists. Clin Infect Dis (2004) 6.45
Is the ADA/EASD algorithm for the management of type 2 diabetes (January 2009) based on evidence or opinion? A critical analysis. Diabetologia (2010) 4.33
Concentrations of pravastatin and lovastatin in cerebrospinal fluid in healthy subjects. Clin Neuropharmacol (1991) 1.77
Electroretinographic testing as an aid in detection of carriers of X-chromosome-linked retinitis pigmentosa. Am J Ophthalmol (1979) 1.75
Lipid-altering efficacy of ezetimibe/simvastatin 10/20 mg compared with rosuvastatin 10 mg in high-risk hypercholesterolaemic patients inadequately controlled with prior statin monotherapy - The IN-CROSS study. Int J Clin Pract (2009) 1.61
An elective-titration study of the comparative effectiveness of two angiotensin II-receptor blockers, irbesartan and losartan. Irbesartan/Losartan Study Investigators. Clin Ther (1998) 1.54
Lipid-altering efficacy of ezetimibe/simvastatin 10/40 mg compared with doubling the statin dose in patients admitted to the hospital for a recent coronary event: the INFORCE study. Int J Clin Pract (2008) 1.50
Induction of the c-fos proto-oncogene in rat amygdala during unconditioned and conditioned fear. Brain Res (1991) 1.26
Predator odor as an unconditioned fear stimulus in rats: elicitation of freezing by trimethylthiazoline, a component of fox feces. Behav Neurosci (2000) 1.22
Effect of (-)-hydroxycitrate upon the accumulation of lipid in the rat. I. Lipogenesis. Lipids (1974) 1.21
Neurotoxic lesions of the lateral nucleus of the amygdala decrease conditioned fear but not unconditioned fear of a predator odor: comparison with electrolytic lesions. J Neurosci (2001) 1.08
Quenching: inhibition of development and expression of amygdala kindled seizures with low frequency stimulation. Neuroreport (1995) 1.06
Protein structure and energy landscape dependence on sequence using a continuous energy function. J Comput Biol (1997) 1.05
Effect of (-)-hydroxycitrate upon the accumulation of lipid in the rat. II. Appetite. Lipids (1974) 1.03
Matrix study of irbesartan with hydrochlorothiazide in mild-to-moderate hypertension. Am J Hypertens (1999) 1.01
Specific induction of early growth response gene 1 in the lateral nucleus of the amygdala following contextual fear conditioning in rats. Neuroscience (2000) 1.00
Efficacy of ezetimibe/simvastatin 10/20 and 10/40 mg compared with atorvastatin 20 mg in patients with type 2 diabetes mellitus. Diabetes Obes Metab (2007) 0.99
Lipid-altering efficacy and safety profile of combination therapy with ezetimibe/statin vs. statin monotherapy in patients with and without diabetes: an analysis of pooled data from 27 clinical trials. Diabetes Obes Metab (2011) 0.97
Altered sympathetic activity during development of diet-induced obesity in rat. Am J Physiol (1983) 0.97
Oxidation and ketogenesis in hepatocytes of lean and obese Zucker rats. Metabolism (1982) 0.96
Regulation of protein kinase C by short term hyperglycaemia in human platelets in vivo and in vitro. Diabetologia (2001) 0.96
Comparative effects of (--)-hydroxycitrate and (+)-allo-hydroxycitrate on acetyl CoA carboxylase and fatty acid and cholesterol synthesis in vivo. Lipids (1977) 0.95
Resistance to diet-induced obesity: food intake, pancreatic sympathetic tone, and insulin. Am J Physiol (1987) 0.94
Single-dose pharmacokinetics of pravastatin and metabolites in patients with renal impairment. J Clin Pharmacol (1992) 0.93
Studies on the antiobesity activity of tetrahydrolipstatin, a potent and selective inhibitor of pancreatic lipase. Int J Obes (1987) 0.92
Metabolic consequences of fasting in old lean and obese Zucker rats. Metabolism (1980) 0.92
Relationship between sympathetic activity and diet-induced obesity in two rat strains. Am J Physiol (1983) 0.91
MOPED: method for optimizing physical energy parameters using decoys. J Comput Chem (2003) 0.91
Factors governing single-trial contextual fear conditioning in the weanling rat. Behav Neurosci (2009) 0.91
Cone and rod function in vitamin A deficiency with chronic alcoholism and in retinitis pigmentosa. Am J Ophthalmol (1977) 0.91
Ezetimibe added to atorvastatin compared with doubling the atorvastatin dose in patients at high risk for coronary heart disease with diabetes mellitus, metabolic syndrome or neither. Diabetes Obes Metab (2010) 0.89
Studies of origins of abnormal sympathetic function in obese Zucker rats. Am J Physiol (1983) 0.89
Carbohydrate metabolism in lean and obese Zucker rats. Metabolism (1979) 0.89
Effect of (-)-hydroxycitrate on development of obesity in the Zucker obese rat. Am J Physiol (1981) 0.88
Impact of peripheral arterial disease in patients with diabetes--results from PROactive (PROactive 11). Atherosclerosis (2008) 0.88
Metabolic regulation as a control for lipid disorders. I. Influence of (--)-hydroxycitrate on experimentally induced obesity in the rodent. Am J Clin Nutr (1977) 0.88
Two HLA DRB 1 alleles confer independent genetic susceptibility to Graves disease: relevance of cross-population studies. Am J Med Genet (2001) 0.87
Lipid-altering efficacy of switching from atorvastatin 10 mg/day to ezetimibe/simvastatin 10/20 mg/day compared to doubling the dose of atorvastatin in hypercholesterolaemic patients with atherosclerosis or coronary heart disease. Int J Clin Pract (2005) 0.87
Pharmacokinetic interaction between propranolol and the HMG-CoA reductase inhibitors pravastatin and lovastatin. Br J Clin Pharmacol (1991) 0.87
Differential expression of EGR-1 mRNA in the amygdala following diazepam in contextual fear conditioning. Brain Res (2000) 0.85
Preliminary Doppler studies on the uterine artery and myometrium in trophoblastic tumours requiring chemotherapy. Br J Obstet Gynaecol (1990) 0.85
Practical use of duplex Doppler analysis of the renal vasculature in critically ill patients. Lancet (1989) 0.85
Doppler time velocity waveform studies of the uterine artery and uterus. Br J Obstet Gynaecol (1989) 0.85
Induction of NGFI-B mRNA following contextual fear conditioning and its blockade by diazepam. Brain Res Mol Brain Res (2000) 0.85
Infusion of cholecystokinin between meals into free-feeding rats fails to prolong the intermeal interval. Physiol Behav (1987) 0.84
Abnormal sympatho- adrenal function and plasma catecholamines in obese Zucker rats. Pharmacol Biochem Behav (1980) 0.84
Metabolic features of diet-induced obesity without hyperphagia in young rats. Am J Physiol (1986) 0.84
Pravastatin and lovastatin in cerebrospinal fluid. Clin Neuropharmacol (1993) 0.83
Preference for rizatriptan 10-mg wafer vs. eletriptan 40-mg tablet for acute treatment of migraine. Cephalalgia (2006) 0.82
Diet-dependent hyperplastic growth of adipose tissue in hypothalamic obese rats. Am J Physiol (1984) 0.82
Brown adipose and metabolic features of chronic diet-induced obesity. Am J Physiol (1985) 0.82
Decreased hepatic production of very low density lipoproteins following activation of fatty acid oxidation by Ro 22-0654. J Lipid Res (1985) 0.82
Defective catecholamine metabolism in peripheral organs of genetically obese Zucker rats. Brain Res (1981) 0.82
Analogs of Ac-CCK-7 incorporating dipeptide mimics in place of Met28-Gly29. J Med Chem (1992) 0.81
Comparative effects of saturated and unsaturated lipids on hepatic lipogenesis and cholesterogenesis in vivo in the meal-fed rat. J Nutr (1978) 0.81
Effects of TRH on acoustic startle, conditioned fear and active avoidance in rats. Neuropeptides (2000) 0.81
Carboxylic acids and tetrazoles as isosteric replacements for sulfate in cholecystokinin analogues. J Med Chem (1991) 0.81
Dietary obesity and neonatal sympathectomy. I. Effects on body composition and brown adipose. Am J Physiol (1984) 0.81
Sympathetic activity in thyroid-treated Zucker rats. Am J Physiol (1982) 0.81
The effect of diet and chronic obesity on brain catecholamine turnover in the rat. Pharmacol Biochem Behav (1986) 0.81
Synthesis and biological evaluation of pNPY fragments. Int J Pept Protein Res (1988) 0.81
Impact of a combination of a calcium antagonist and a beta-blocker on cell- and copper-mediated oxidation of LDL and on the accumulation and efflux of cholesterol in human macrophages and murine J774 cells. Arterioscler Thromb Vasc Biol (1997) 0.80
Lasting effect of repeated cocaine administration on acoustic and fear-potentiated startle in rats. Psychopharmacology (Berl) (1999) 0.80
SNPs of PSMA6 gene--investigation of possible association with myocardial infarction and type 2 diabetes mellitus. Genetika (2007) 0.80
Adenosine involvement in postictal events in amygdala-kindled rats. Epilepsy Res (1990) 0.80
Metabolic regulation as a control for lipid disorders. II. Influence of (--)-hydroxycitrate on genetically and experimentally induced hypertriglyceridemia in the rat. Am J Clin Nutr (1977) 0.79
Effects of diet and obesity on brown adipose metabolism. Am J Physiol (1984) 0.79
Efficacy of ezetimibe/simvastatin 10/40 mg compared to doubling the dose of low-, medium- and high-potency statin monotherapy in patients with a recent coronary event. Cardiology (2008) 0.79
Stronger association of common variants in TCF7L2 gene with nonobese type 2 diabetes in the Latvian population. Exp Clin Endocrinol Diabetes (2012) 0.78
Attenuation of kindling-induced decreases in NT-3 mRNA by thyroid hormone depletion. Epilepsy Res (1998) 0.78
Discriminative stimulus properties of amphetamine and other stimulants in lead-exposed and normal rats. Pharmacol Biochem Behav (1986) 0.78
Efficacy and safety of ezetimibe co-administered with ongoing atorvastatin therapy in achieving low-density lipoprotein goal in patients with hypercholesterolemia and coronary heart disease. Int J Clin Pract (2005) 0.78
Prevalence of nosocomial infections in two Latvian hospitals. Euro Surveill (2003) 0.78
Effect on blood pressure control of switching from valsartan monotherapy to losartan/hydrochlorothiazide in Asian patients with hypertension: results of a multicentre open-label trial. Curr Med Res Opin (2006) 0.78
Differences between lean and obese Zucker rats: the effect of poorly absorbed dietary lipid on energy intake and body weight gain. J Nutr (1978) 0.78
Safety profile of statins alone or combined with ezetimibe: a pooled analysis of 27 studies including over 22,000 patients treated for 6-24 weeks. Int J Clin Pract (2012) 0.77
Association of microsatellite polymorphisms of the human 14q13.2 region with type 2 diabetes mellitus in Latvian and Finnish populations. Ann Hum Genet (2007) 0.77
Noninvasive monitoring of renal blood flow characteristics during acute renal failure in man. Intensive Care Med (1990) 0.77
Differential regulation of basal and kindling-induced TRH mRNA expression by thyroid hormone in the hypothalamic and limbic structures. Neuroendocrinology (1996) 0.77
An optimal structure-discriminative amino acid index for protein fold recognition. Biophys J (2004) 0.76
Comparison of irbesartan vs felodipine in the regression after 1 year of left ventricular hypertrophy in hypertensive patients (the SILVER trial). Study of Irbesartan in Left VEntricular hypertrophy Regression. J Hum Hypertens (1998) 0.76
Structure activity studies of tryptophan30 modified analogs of Ac-CCK-7. Int J Pept Protein Res (1992) 0.76
Anti-obesity activity of a novel lipid synthesis inhibitor. Int J Obes (1984) 0.76
Nociceptive neurons of the raccoon lateral thalamus. J Neurophysiol (1993) 0.76
Cognitive training in Parkinson's disease reduces cognitive decline in the long term. Eur J Neurol (2014) 0.76
Changes in lipid metabolism in diet-induced obesity. Metabolism (1985) 0.76
LDL-C goal attainment with the addition of ezetimibe to ongoing simvastatin treatment in coronary heart disease patients with hypercholesterolemia. Curr Med Res Opin (2005) 0.76
Trefoil factor 3 is required for differentiation of thyroid follicular cells and acts as a context-dependent tumor suppressor. Neoplasma (2015) 0.76
Contingent tolerance to the anticonvulsant effects of carbamazepine: relationship to loss of endogenous adaptive mechanisms. Brain Res Brain Res Rev (1995) 0.76
Double-pulse stimulation of startle-like responses in rats: refractory periods and temporal summation. Brain Res (1989) 0.76
Analogs of CCK incorporating conformationally constrained replacements for Asp32. J Med Chem (1992) 0.75
The brain decade in debate: III. Neurobiology of emotion. Braz J Med Biol Res (2001) 0.75
Age of testing as a factor in the behavioral effects of early lead exposure in rats. Pharmacol Biochem Behav (1985) 0.75
Prolonged postictal depression in amygdala-kindled rats by the adenosine analog, L-phenylisopropyladenosine. Exp Neurol (1985) 0.75
Interpretation of duplex Doppler ultrasound in renal transplants in the early postoperative period. Nephrol Dial Transplant (1993) 0.75
Anxiety in dental patients: a study of three phases of state anxiety in three treatment groups. Psychol Rep (1979) 0.75
Suppressant effects of naltrexone on water intake in rats. Pharmacol Biochem Behav (1979) 0.75